ZENV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ZENV is not a good buy right now for an impatient investor. The stock remains in a bearish trend (SMA200 > SMA20 > SMA5) with no Intellectia buy signals and weak forward-return odds over the next week/month. Without a clear catalyst or momentum confirmation, the risk/reward is unattractive at the current $0.90 level.
Price/levels: ZENV closed at $0.90, below the pivot ($0.92). Near-term support is S1 $0.867 then S2 $0.834; resistance is R1 $0.974 then R2 $1.007. Trend: Bearish moving-average stack (SMA200 > SMA20 > SMA5) signals a prevailing downtrend. Momentum: MACD histogram is positive (0.0107) but contracting, suggesting fading bullish momentum rather than a strong upswing. RSI(6) ~43.9 is neutral-to-soft, not showing an oversold bounce setup. Pattern-based outlook: Similar-pattern stats imply modest downside bias (-1.78% next week, -2.04% next month).
Intellectia Proprietary Trading Signals
Revenue growth in 2025/Q2 (+23.6% YoY) and improved net income/EPS versus prior year (loss narrowing meaningfully).
No significant hedge fund or insider trend pressure (both neutral), reducing the chance of near-term forced selling from those groups.
Gross margin deterioration in 2025/Q2 (down sharply YoY to 19.73), which can pressure profitability and valuation.
Still loss-making (net income negative) despite improvement.
No recent news flow in the past week—no visible near-term catalyst to flip sentiment.
Technical backdrop remains bearish with price below pivot and key moving averages.
Latest quarter: 2025/Q2. Revenue rose to 285,701,000 (+23.60% YoY), indicating top-line growth. Net income improved to -41,983,000 (loss narrowed vs. prior year) and EPS improved to -0.8, showing reduced losses. However, gross margin fell to 19.73 (down materially YoY), a key negative trend that can offset revenue growth and limit near-term rerating.
No analyst rating/price target change data was provided, so there is no observable recent trend in Wall Street stance. Pros likely focus on accelerating revenue growth and improving losses; cons would center on sharp gross-margin compression, ongoing losses, and a bearish technical trend—overall not supportive of an immediate buy.
